Research Topics
| M A JudsonSummaryAffiliation: Medical University of South Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
Two year prognosis of sarcoidosis: the ACCESS experienceMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA
Sarcoidosis Vasc Diffuse Lung Dis 20:204-11. 2003..Several factors associated with improved or worse outcome over two years were identified...
The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosisMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, USA
Respirology 13:97-102. 2008..In particular, the study sought to determine whether the CXR changes were a reliable indicator of disease exacerbation...
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trialM A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC, USA
Eur Respir J 31:1189-96. 2008..Infliximab may be beneficial compared with placebo in the treatment of extrapulmonary sarcoidosis in patients already receiving corticosteroids, as assessed by the severity tool described in the present study...
The diagnosis of sarcoidosisMarc A Judson
Division of Pulmonary and Critical Care Medicine, CSB 812, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29466, USA
Clin Chest Med 29:415-27, viii. 2008..The end result of this diagnostic evaluation for sarcoidosis is neither a definitive diagnosis nor an exclusion of the diagnosis, but rather a statistical likelihood of the disease...
A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI)Marc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, CSB 812, 96 Jonathan Lucas Street, Charleston, SC 29425, United States
Med Hypotheses 68:1080-7. 2007..Although this instrument is presently not validated, it is hoped that it will undergo study as it rationally accounts for several problems of previous assessment instruments...
Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balanceMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
Chest 135:1358-9. 2009..We suspect that infliximab disrupted the T-helper (Th) type 1-Th2 lymphocyte balance such that Th2 cytokines were left relatively unopposed, promoting the development of ABPA...
The diagnostic pathway to sarcoidosisMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA
Chest 123:406-12. 2003..To examine the time from the first physician visit to the diagnosis of sarcoidosis...
The management of sarcoidosis by the primary care physicianMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, USA
Am J Med 120:403-7. 2007..This article outlines the approach to the evaluation and treatment of sarcoidosis by primary care physicians...
Extrapulmonary sarcoidosisMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29466, USA
Semin Respir Crit Care Med 28:83-101. 2007..This article reviews the clinical presentation and therapy of extrapulmonary sarcoidosis...
Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South CarolinaMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Semin Respir Crit Care Med 28:75-82. 2007..Atypical presentations may result in a delay in diagnosis as well as unnecessary treatment or diagnostic testing. We discuss four patients with an unusual presentation of thoracic sarcoidosis seen at our Sarcoidosis Clinic...
Bullous sarcoidosis: a report of three casesM A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA
Chest 114:1474-8. 1998..Additional clues are the presence of mediastinal adenopathy on a chest radiograph or a CT scan and a history consistent with extrapulmonary sarcoidosis...
An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatmentM A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA
Chest 115:1158-65. 1999..This article describes the use of corticosteroids for pulmonary sarcoidosis in terms of the above six phases. The proposed dosing schedules are based on the natural history of the disease and the results from published treatment studies...
Sarcoidosis: clinical presentation, diagnosis, and approach to treatmentMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Am J Med Sci 335:26-33. 2008..Sarcoidosis may remit spontaneously or remain stable. Therefore, therapy is not mandated for the disease. This report reviews the clinical presentation, diagnostic approach, and treatment of sarcoidosis...
Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroidM A Judson
Division of Vascular and Interventional Radiology, Medical University of South Carolina, Charleston, SC 29425, USA
Chest 120:316-7. 2001..CT-guided direct intralesional transthoracic injection of dexamethasone resulted in resolution of the patient's symptoms and a dramatic reduction in the size of the mass within 2 months...
Comparison of sarcoidosis phenotypes among affected African-American siblingsMarc A Judson
Division of Pulmonary and Critical Care Medicine CSB 812, Medical University of South Carolina, Charleston, SC 29425, USA
Chest 130:855-62. 2006..To test the hypothesis that sibling pairs, who share genes and environmental exposures, might have similar phenotypic expressions of sarcoidosis beyond what would be expected by chance alone...
Current pharmacotherapy of allergic bronchopulmonary aspergillosisM A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, USA
Expert Opin Pharmacother 2:1065-71. 2001..Multiple asthmatic exacerbations in a patient with ABPA suggest that chronic steroid therapy should be used. Itraconazole appears useful as a steroid sparing agent...
The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosisMarc A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Sarcoidosis Vasc Diffuse Lung Dis 23:51-7. 2006..Few patients can tolerate doses of greater than 100 mg/day. Thalidomide may have been corticosteroid-sparing in a subgroup of these patients...
Chronic cutaneous lesions of sarcoidosisRichard M Marchell
Department of Dermatology, Medical University of South Carolina, SC 29425, USA
Clin Dermatol 25:295-302. 2007..This article will review the epidemiology, diagnostic evaluation, and description of the various chronic skin lesions of sarcoidosis. Various images of these skin lesions will be demonstrated...
Sarcoidosis associated with an elevated serum CA 125 level: description of a case and a review of the literatureMeena Kalluri
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
Am J Med Sci 334:441-3. 2007..It has also been reported to be elevated in certain granulomatous conditions. We describe a patient with sarcoidosis and an elevated serum CA 125 level and review the medical literature on this topic...
Treatment of sarcoidosis with infliximabJohn D Doty
Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, 96 Jonathan Lucas St, Suite 812-CSB, PO Box 250623, Charleston, SC 29425, USA
Chest 127:1064-71. 2005..Infliximab appears to be steroid sparing. Patients receiving the drug should be screened for latent tuberculosis and lymphoproliferative disorders...
Pleural effusions in a series of 181 outpatients with sarcoidosisJohn T Huggins
Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, PO Box 250625, Charleston, SC 29425, USA
Chest 129:1599-604. 2006..We performed thoracic ultrasonography prospectively in consecutive outpatients with sarcoidosis to determine the frequency of PEs caused by sarcoidosis and to define their pleural fluid characteristics...
Cutaneous sarcoidosisRichard M Marchell
Department of Dermatology, Medical University of South Carolina, Charleston, SC 29425, USA
Semin Respir Crit Care Med 31:442-51. 2010..Tumor necrosis factor-alpha (TNF-alpha) antagonists such as infliximab may have a role in cutaneous sarcoidosis, especially in refractory cases that are resistant to the standard regimens...
Ambrisentan for sarcoidosis associated pulmonary hypertensionM A Judson
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, USA
Sarcoidosis Vasc Diffuse Lung Dis 28:139-45. 2011..Sarcoidosis associated pulmonary hypertension (SAPH) is associated with significant morbidity and mortality. There is a paucity of information concerning therapy for this condition...
Endoscopic ultrasonography with fine-needle aspiration: an accurate and simple diagnostic modality for sarcoidosisG Mishra
Digestive Disease Center, Medical University of South Carolina, Charleston, USA
Endoscopy 31:377-82. 1999..The present study is a descriptive, retrospective one using endoscopic ultrasound with fine-needle aspiration (EUS-FNA) of mediastinal lymph nodes in seven patients with sarcoidosis...
Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimenJohn D Doty
Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina Charleston, SC 29425, USA
Chest 124:2023-6. 2003..CONCLUSION: Short-course cyclophosphamide appears to be a reasonable, steroid-sparing treatment option for patients with corticosteroid-refractory neurosarcoidosis...
Clinical outcomes in sarcoidosis after cessation of infliximab treatmentEfstratios Panselinas
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
Respirology 14:522-8. 2009..Infliximab appears to be efficacious for the treatment of recalcitrant forms of sarcoidosis. However, there are minimal data concerning the course of sarcoidosis once infliximab is discontinued...
Mycobacterium scrofulaceum infection presenting as lung nodules in a heart transplant recipientG P LeMense
Division of Pulmonary Critical Care Medicine, Medical University of South Carolina, Charleston 29425
Chest 106:1918-20. 1994..Atypical mycobacteria have not been reported as the etiology of pulmonary nodules in a heart transplant recipient. We report a case of Mycobacterium scrofulaceum infection presenting as three discrete pulmonary nodules...
Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbationsBrian P McKinzie
Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Am J Med Sci 339:1-4. 2010..To the best of our knowledge, this is the shortest period of time over which the treatment of pulmonary sarcoidosis with corticosteroids has been assessed...
Sarcoidosis presenting as bilateral vocal cord paralysis from bilateral compression of the recurrent laryngeal nerves from thoracic adenopathyCharles S Coffey
Department of Otolaryngology Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina 29425, USA
J Voice 23:631-4. 2009..The presenting symptoms, clinical outcome, radiographs and laryngeal findings are discussed in detail. Sarcoidosis should therefore be added to the differential diagnosis of bilateral vocal fold paralysis...
Vaginal involvement in a patient with sarcoidosisSarah L Allen
Department of Internal Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
Chest 137:455-6. 2010..To our knowledge, this is the first reported case of this entity. An additional unusual finding was that her symptoms of gynecologic sarcoidosis occurred at the time of initial presentation of her pulmonary sarcoidosis...
Staple metalloptysis after lung resection for mycetoma: a case report and a review of the literatureEfstratios Panselinas
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29466, USA
Am J Med Sci 336:365-7. 2008..Although metalloptysis usually requires no therapy, it may indicate an active infectious process that requires appropriate therapy...
Carpal tunnel syndrome in sarcoidosisG W Niemer
Division of Rheumatology, Medical University of South Carolina, Charleston, USA
Sarcoidosis Vasc Diffuse Lung Dis 18:296-300. 2001..Our findings suggest that CTS is common in sarcoidosis...
Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus studyAmanda C Schutt
Medical University of South Carolina Medical Center and College of Pharmacy, Charleston, SC 29425, USA
Respir Med 104:717-23. 2010..The objective was to survey sarcoidosis experts concerning the treatment of pulmonary sarcoidosis and attempt to reach a consensus by these experts using a Delphi method...
Pleural effusion caused by trapped lungJay T Heidecker
Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
South Med J 96:510-1. 2003..Histologic examination of the lung, visceral and parietal pleura, and the fibrous adhesions all revealed noncaseating granulomas...
A neutropenic patient with rapidly progressive lung lesionDarryl R Pauls
Medical University of South Carolina, 169 Ashley Avenue, Charleston, SC 29425, USA
Chest 126:1364-7. 2004
Trouble below the surfaceCharles M Wiener
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
Am J Med 119:828-31. 2006
Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think?S M Wildi
Digestive Disease Center, Medical University of South Carolina, Charleston, SC 29425, USA
Thorax 59:794-9. 2004..The reported sensitivity and specificity must be appreciated in the context of the difficult and often incomplete clinical diagnosis of sarcoidosis...
Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literatureWendy Bullington
Department of Pharmacy Services and the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Am J Med Sci 333:290-2. 2007..To report a case of valproic acid-induced eosinophilic pleural effusion and to review the existing literature...
Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosisSusan Garwood
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
Chest 132:1298-304. 2007..The purpose of this study was to assess the utility of EBUS-TBNA for pulmonary sarcoidosis...
Health-related quality of life of persons with sarcoidosisChristopher E Cox
Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina, Chapel Hill, NC, USA
Chest 125:997-1004. 2004..To describe the health-related quality of life (HRQL) and mental health of persons with sarcoidosis, as well as to assess physician-patient agreement about the presence of sarcoidosis symptoms...
The spectrum of biopsy sites for the diagnosis of sarcoidosisAlvin S Teirstein
Mount Sinai Medical Center, New York, NY 10029, USA
Sarcoidosis Vasc Diffuse Lung Dis 22:139-46. 2005..Clinicians must decide which site offers the best chance of achieving a diagnostic biopsy with the least patient risk and discomfort...
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvementRobert P Baughman
University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
Am J Respir Crit Care Med 174:795-802. 2006..Evidence suggests that tumor necrosis factor (TNF)-alpha plays an important role in the pathophysiology of sarcoidosis...
Thalidomide for chronic sarcoidosisRobert P Baughman
Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA
Chest 122:227-32. 2002..Lupus pernio is a skin manifestation of sarcoidosis that does not remit spontaneously, and was used as a marker of efficacy of thalidomide for sarcoidosis...
Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systemsRobert P Baughman
University of Cincinnati Medical Center, Cincinnati, Ohio 45267, USA
Am J Clin Dermatol 9:155-61. 2008..Facial lesions including lupus pernio are often a form of chronic cutaneous sarcoidosis...
The Sarcoidosis Health Questionnaire: a new measure of health-related quality of lifeChristopher E Cox
Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Am J Respir Crit Care Med 168:323-9. 2003..The SHQ alone was sensitive to differences in HRQL based on the number of involved organ systems. In conclusion, we have developed a self-completed HRQL questionnaire for U.S. patients with sarcoidosis...
Use of fluticasone in acute symptomatic pulmonary sarcoidosisRobert P Baughman
Department of Internal Medicine, University of Cincinnati Medical Center, OH 45267 0565, USA
Sarcoidosis Vasc Diffuse Lung Dis 19:198-204. 2002..Inhaled corticosteroids have been used with variable success in sarcoidosis. The role of the inhaled corticosteroid fluticasone in symptomatic pulmonary patients was studied...
A case control etiologic study of sarcoidosis: environmental and occupational risk factorsLee S Newman
National Jewish Medical and Research Center and Univresity of Colorado Health Scienes Center, Denver, CO 80206, USA
Am J Respir Crit Care Med 170:1324-30. 2004..65, CI 0.51-0.82). The study did not identify a single, predominant cause of sarcoidosis. We identified several exposures associated with sarcoidosis risk, including insecticides, agricultural employment, and microbial bioaerosols...
Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomicsGloria E Westney
Pulmonary and Critical Care Section, Department of Medicine, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310, USA
Clin Chest Med 27:453-62, vi. 2006..The influences of genetics and socioeconomic status on the development and phenotypic expression of sarcoidosis will be better understood as the mechanisms of disease development are uncovered...
Pulmonary and psychosocial findings at enrollment in the ACCESS studyHenry Yeager
Pulmonary, Critical Care, and Sleep Medicine, Georgetown University Medical Center, Washington, DC 20057, USA
Sarcoidosis Vasc Diffuse Lung Dis 22:147-53. 2005..To assess lung involvement and the association of demographic and psychosocial factors with respiratory health in 736 persons with sarcoidosis at enrollment in A Case Control Etiologic Study of Sarcoidosis (ACCESS)...
Relationship of environmental exposures to the clinical phenotype of sarcoidosisMary Elizabeth Kreider
Division of Pulmonary and Critical Care, University of Pennsylvania School of Medicine, 826 Gates Building, 3400 Spruce St, Philadelphia, PA 19104, USA
Chest 128:207-15. 2005..We examined the relationship between environmental and occupational exposures, and the clinical phenotype of sarcoidosis...
A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) studyBenjamin A Rybicki
Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, MI 48202, USA
Sarcoidosis Vasc Diffuse Lung Dis 22:115-22. 2005..In the United States of America, African Americans have a higher sarcoidosis incidence and suffer greater morbidity than Caucasians...
A new tool to assess sarcoidosis severityYasmine S Wasfi
Pulmonary, Allergy, and Critcal Care Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Chest 129:1234-45. 2006..This preliminary tool has potential applicability in the assessment of disease severity in sarcoidosis research...
Highly active antiretroviral therapy for HIV with tuberculosis: pardon the granulomaMarc A Judson
Chest 122:399-400. 2002
The etiologic agent of sarcoidosis: what if there isn't one?Marc A Judson
Chest 124:6-8. 2003
Quality of life evaluation in sarcoidosis: current status and future directionsDavid E Victorson
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA
Curr Opin Pulm Med 14:470-7. 2008..To describe the current state of knowledge concerning health-related quality of life research in sarcoidosis and suggest new approaches that could be explored...
Bird-years as well as pack-yearsMarc A Judson
Chest 125:353-4. 2004
The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosisMark T Wagner
Sarcoidosis Vasc Diffuse Lung Dis 22:235. 2005
Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS)Juliana Barnard
Division of Environmental and Occupational Health Sciences, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA
J Occup Environ Med 47:226-34. 2005..To determine whether specific occupations and industries may be associated with sarcoidosis...
Cardiac sarcoidosis: there is no instant replayMarc A Judson
Chest 128:3-6. 2005
SarcoidosisChristopher E Cox
Department of Medicine, Duke University Medical Center, Box 3221, Room 275, MSRB, Research Drive, Durham, NC 27710, USA
Med Clin North Am 89:817-28. 2005..Improving access to care and addressing other disparities in health care may help to bridge the gap in health outcomes observed between patients...
Organizing pneumoniaFotis Drakopanagiotakis
Third Pulmonary Department, Sismanoglio General Hospital, Athens, Greece
Am J Med Sci 335:34-9. 2008..Relapses occur frequently, usually when treatment is withdrawn or tapered. The prognosis is good in most of the cases of COP, whereas in SOP it is dependent on the underlying cause...
